2001
DOI: 10.1074/jbc.m100239200
|View full text |Cite
|
Sign up to set email alerts
|

The Identification of Prx1 Transcription Regulatory Domains Provides a Mechanism for Unequal Compensation by thePrx1 and Prx2 Loci

Abstract: Transcription regulatory domains of the Prx1a and Prx1b homeoproteins were analyzed in transient transfection assays using artificial promoters as well as an established downstream target promoter (tenascin-c). Activation and repression domains were detected in their common amino end. In the carboxyl end of Prx1a an activation domain and an inhibition/masking region (OAR domain) were detected. The Prx1b isoform, generated by alternative splicing, does not contain these carboxyl activation or inhibition domains… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
69
0

Year Published

2001
2001
2021
2021

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 57 publications
(72 citation statements)
references
References 44 publications
3
69
0
Order By: Relevance
“…In Cart1 and in Prx proteins the aristaless domain has an inhibitory function (45). This does not seem to be the case for Alx3, because deletion of the region that contains the aristaless domain (Alx3-(1-279)) does not result in transcriptional enhancement in transfected cells, consistent with the notion that Alx3 contains a divergent aristaless domain that appears not to be functional (46).…”
Section: Proline-rich Domains Confer Transcriptional Transactivation supporting
confidence: 61%
“…In Cart1 and in Prx proteins the aristaless domain has an inhibitory function (45). This does not seem to be the case for Alx3, because deletion of the region that contains the aristaless domain (Alx3-(1-279)) does not result in transcriptional enhancement in transfected cells, consistent with the notion that Alx3 contains a divergent aristaless domain that appears not to be functional (46).…”
Section: Proline-rich Domains Confer Transcriptional Transactivation supporting
confidence: 61%
“…Continuing with this model, if the regulatory mechanism were ever rendered nonfunctional due to mutations, then it is likely that the presence of Prx1 protein may contribute to heart malformations or altered cardiac function. Prx1 is a potent activator of TN-C transcription (Norris and Kern, 2001). In at least one cardiac disease state, aortic valve stenosis, TN-C is up-regulated (Li et al, 2000).…”
Section: Prx1 Expression In the Murine And Avian Heartmentioning
confidence: 99%
“…The OAR (a.k.a. aristaless) domain was shown to inhibit or mask nearby potent activation domains of Prx1a (Norris and Kern, 2001b). Natural and engineered mouse mutants of several paired-type homeoproteins with an OAR domain resulted in defects of cartilage and bone development (Zhao et al, 1996;Qu et al, 1997Qu et al, , 1998Qu et al, , 1999ten Berge et al, 1998b;Lu et al, 1999a,b;.…”
Section: Introductionmentioning
confidence: 99%
“…and E.S.C., unpublished data). Biochemical assessment of the two Prx1 isoforms in a transient cotransfection system defined that Prx1a is a transcriptional activator and Prx1b is a transcriptional repressor (Norris and Kern, 2001b). Repressor activity within the Prx1b protein was localized to the carboxy terminus, encoded within the alternatively spliced exon 4.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation